More Concern Over Morphine, Clopidogrel Interaction in ACS More Concern Over Morphine, Clopidogrel Interaction in ACS
New data suggest use of morphine delays the absorption of clopidogrel and leads to an increase in short-term cardiac ischemic events.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 23, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Clopidogrel Appropriate for PCI in Liver Transplant Candidates Clopidogrel Appropriate for PCI in Liver Transplant Candidates
In patients with decompensated cirrhosis undergoing percutaneous coronary intervention (PCI), clopidogrel safely inhibits platelet aggregation, according to a small study of liver-transplant candidates.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 8, 2020 Category: Surgery Tags: Cardiology News Source Type: news

Genetic Testing Spots Clopidogrel Responders After PCI for STEMI Genetic Testing Spots Clopidogrel Responders After PCI for STEMI
Guidelines for the management of acute STEMI patients undergoing PCI may need to be revised after a genotype-guided protocol giving clopidogrel to responders reduced bleeding rates, say experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 3, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Optimal Dual Antiplatelet Duration After Minor Stroke or TIA? Optimal Dual Antiplatelet Duration After Minor Stroke or TIA?
Pooled data from two large trials points to a net benefit associated with 21 days of clopidogrel – aspirin therapy after a minor stroke or transient ischemic attack.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - August 29, 2019 Category: Intensive Care Tags: Neurology & Neurosurgery News Source Type: news

Ultrasound-Guided Thoracentesis Appears Safe With Novel Oral Anticoagulants or Clopidogrel Ultrasound-Guided Thoracentesis Appears Safe With Novel Oral Anticoagulants or Clopidogrel
Rates of significant bleeding complications are very low after ultrasound-guided thoracentesis in patients on novel oral anticoagulants (NOACs) and/or clopidogrel, a retrospective analysis found.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 6, 2019 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

clopidogrel bisulfate (Plavix)
Title: clopidogrel bisulfate (Plavix)Category: MedicationsCreated: 6/6/1999 12:00:00 AMLast Editorial Review: 7/30/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 30, 2019 Category: Cardiology Source Type: news

Plavix (clopidogrel) vs. Xarelto (rivaroxaban)
Title: Plavix (clopidogrel) vs. Xarelto (rivaroxaban)Category: MedicationsCreated: 7/19/2019 12:00:00 AMLast Editorial Review: 7/19/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 19, 2019 Category: Cardiology Source Type: news

Plavix (clopidogrel) vs. Effient (prasurgrel)
Title: Plavix (clopidogrel) vs. Effient (prasurgrel)Category: MedicationsCreated: 7/19/2019 12:00:00 AMLast Editorial Review: 7/19/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 19, 2019 Category: Cardiology Source Type: news

Antithrombotic agents and traumatic brain injury in the elderly population: hemorrhage patterns and outcomes - Scotti P, S ├ęguin C, Lo BWY, De Guise E, Troquet JM, Marcoux J.
OBJECTIVE: Among the elderly, use of antithrombotics (ATs), antiplatelets (APs; aspirin, clopidogrel), and/or anticoagulants (ACs; warfarin, direct oral ACs [DOACs; dabigatran, rivaroxaban, apixaban]) to prevent thromboembolic events must be carefully weig... (Source: SafetyLit)
Source: SafetyLit - July 8, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Plavix (clopidogrel) vs. Coumadin (warfarin)
Title: Plavix (clopidogrel) vs. Coumadin (warfarin)Category: MedicationsCreated: 6/25/2019 12:00:00 AMLast Editorial Review: 6/25/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 25, 2019 Category: Cardiology Source Type: news

clopidogrel (Plavix) vs. heparin (Hemochron)
Title: clopidogrel (Plavix) vs. heparin (Hemochron)Category: MedicationsCreated: 6/24/2019 12:00:00 AMLast Editorial Review: 6/24/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 24, 2019 Category: Cardiology Source Type: news

Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half
Restarting antiplatelet therapy after intracranial hemorrhage remains controversial, but new evidence suggests aspirin or clopidogrel can significantly reduce recurrent ICH without increased bleeding.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 23, 2019 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Aspirin, Anti-Clotting Meds Safe After Bleeding Stroke: Study
WEDNESDAY, May 22, 2019 -- Taking aspirin or anti-clotting medicines like Plavix won't boost the risk of another stroke if you've already survived a bleeding stroke, a new study suggests. In fact, they might even help guard against a second brain... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 22, 2019 Category: General Medicine Source Type: news

International Laboratories, LLC Issues Voluntary Nationwide Recall of one (1) Lot of Clopidogrel Tablets USP, 75 mg packaged in bottles of 30 tablets Due to Mislabeling NDC # 54458-888-16; Lot # 117099A
International Laboratories, LLC is voluntarily recalling Lot# 117099A of Clopidogrel Tablets, USP 75 mg, packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Clopidogrel tablets USP 75 mg but may contain Clopidogrel 75mg or Simvastatin Tablets USP 10 mg. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 21, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

New Studies Support Dropping Long-term Aspirin After Stenting New Studies Support Dropping Long-term Aspirin After Stenting
The STOPDAPT-2 and SMART-CHOICE trials both suggest extended therapy with clopidogrel or another P2Y12 inhibitor alone may be preferable to dual antiplatelet therapy.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 28, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Ticagrelor is as safe and effective as clopidogrel after heart attack
(American College of Cardiology) Patients given clot busters to treat a heart attack fared equally well if they were given the standard blood thinning medication clopidogrel versus the newer, more potent drug ticagrelor, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2019 Category: International Medicine & Public Health Source Type: news

Stopping aspirin three months after stenting does not increase risk of death
(American College of Cardiology) Patients who stopped taking aspirin three months after receiving a stent to open the heart's arteries but continued taking a P2Y12 inhibitor -- clopidogrel, prasugrel or ticagrelor -- did not experience higher rates of death from any cause, heart attack or stroke after a year compared with those receiving standard therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. Furthermore, patients who stopped taking aspirin after three months had a significantly lower rate of bleeding. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2019 Category: International Medicine & Public Health Source Type: news

Stopping DAPT after one-month improved outcomes in stent patients
(American College of Cardiology) Patients who stopped taking aspirin one month after receiving a stent in the heart's arteries but continued taking the P2Y12 inhibitor clopidogrel fared significantly better after one year compared with those who followed the standard practice of continuing both medications, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2019 Category: International Medicine & Public Health Source Type: news

Drug May Be Safer Option Against Repeat Stroke
The risk of another stroke caused by a blood clot was halved for patients who took the drug Pletal plus aspirin or clopidogrel, versus those who took aspirin or clopidogrel alone. (Source: WebMD Health)
Source: WebMD Health - February 7, 2019 Category: Consumer Health News Source Type: news

Dual Antiplatelet Therapy With Cilostazol Cuts Recurrent Stroke Dual Antiplatelet Therapy With Cilostazol Cuts Recurrent Stroke
New results show cilostazol plus aspirin or clopidogrel reduced recurrent stroke rate by half over aspirin or clopidogrel alone in high-risk stroke patients without increased bleeding.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 7, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Blood Thinning Drug May Be Safer Option Against Recurrent Stroke
THURSDAY, Feb. 7, 2019 -- Taking the blood thinner Pletal (cilostazol) with either aspirin or clopidogrel (best known as Plavix) lowers stroke patients'risk of a subsequent stroke better than taking aspirin or clopidogrel alone, a new study... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 7, 2019 Category: General Medicine Source Type: news

Cilostazol-combo antiplatelet therapy reduced risk for recurrent stroke
(American Heart Association) The long-term combination of cilostazol with aspirin or clopidogrel resulted in fewer recurrent strokes than with aspirin or clopidogrel alone in high-risk patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news

Clopidogrel vs aspirin in acute coronary syndrome in China
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2018 Category: Drugs & Pharmacology Source Type: news

Risk of Adverse CV Events With PPIs Independent of Clopidogrel Risk of Adverse CV Events With PPIs Independent of Clopidogrel
This study aimed to determine whether the observed increase in cardiovascular risk of PPI use with anti-platelet therapy is conferred by PPIs directly or by a pharmacokinetic interaction.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 26, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Modern antiplatelet therapy: When is clopidogrel the right choice?
(Cardiovascular Innovations and Applications) In the current issue of Cardiovascular Innovations and Applications (Volume3, Number 2, 2018, pp. 149-162(14); DOI: 10.15212/CVIA.2017.0049 Punag Divanji and Kendrick Shunk from the University of California San Francisco and The San Francisco Veteran Affairs Hospital, San Francisco, Calif., USA consider when clopidogrel is the right choice in modern antiplatelet therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 10, 2018 Category: International Medicine & Public Health Source Type: news

Plavix and TTP
Title: Plavix and TTPCategory: Doctor's& Expert's views on SymptomsCreated: 5/10/2000 4:41:00 PMLast Editorial Review: 6/13/2018 2:55:08 PM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 13, 2018 Category: Drugs & Pharmacology Source Type: news

Stroke After PCI Linked to Platelet Reactivity on Plavix
(MedPage Today) -- But it's unclear whether link seen in post hoc analysis would be actionable (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 7, 2018 Category: Cardiology Source Type: news

Many Prescriptions for Newer, More Expensive Antiplatelet Agents Go Unfilled Many Prescriptions for Newer, More Expensive Antiplatelet Agents Go Unfilled
Prescriptions for the P2Y12 inhibitors prasugrel hydrochloride and ticagrelor hydrochloride after percutaneous coronary intervention (PCI) are outpacing those for clopidogrel, but many patients are not filling those prescriptions, researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 22, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

POINT: Success at Last for Dual Antiplatelet After Stroke, TIA POINT: Success at Last for Dual Antiplatelet After Stroke, TIA
A combination of clopidogrel plus aspirin reduced major ischemic events vs aspirin alone in patients with minor ischemic stroke or high-risk TIA in this long-awaited trial.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Clopidogrel & #43; Aspirin Cuts Ischemic Events in Stroke, TIA
THURSDAY, May 17, 2018 -- The combination of clopidogrel and aspirin is associated with reduced risk of major ischemic events but increased risk of major hemorrhage among patients with minor ischemic stroke or high-risk transient ischemic attack... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2018 Category: Pharmaceuticals Source Type: news

International study suggests combination therapy may prevent stroke in certain people
(NIH/National Institute of Neurological Disorders and Stroke) Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and aspirin following a small stroke or experiencing minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days. The combination therapy was also associated with an increase in major bleeding, although many of those episodes were non-fatal and did not occur in the brain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 17, 2018 Category: International Medicine & Public Health Source Type: news

After'Mini-Stroke,' Drug Combo (Aspirin Plus Clopidogrel) Could Help Cut Odds for Major Attack
WEDNESDAY, May 16, 2018 -- A dual-drug approach after a " mini-stroke " might maximize a person's odds of avoiding a more major stroke in the months after, research shows. Minor strokes and events known as " transient ischemic attacks " (TIA), or... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 16, 2018 Category: General Medicine Source Type: news

Stroke prevention drug combo shows promise
If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research published in The New England Journal of Medicine. (Source: World Pharma News)
Source: World Pharma News - May 16, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Stroke prevention drug combo shows promise, study says
(University of Texas at Austin) If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research published in The New England Journal of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news

Routine Genotyping for Clopidogrel Response Sustainable in Practice (CME/CE)
(MedPage Today) -- Group's findings support use, but impact remains unproven in trials (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 3, 2018 Category: Cardiology Source Type: news

AHA: Gene Test Predicts Who Won't Benefit From Blood Thinner Plavix
TUESDAY, April 3, 2018 (American Heart Association) -- Heart stent patients with a certain gene mutation may need to consider alternatives to Plavix, a commonly prescribed blood thinner, a new study suggests. Researchers reported Tuesday that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 3, 2018 Category: General Medicine Source Type: news

Genetic test may improve post-stent treatment, outcome
(American Heart Association) A test for specific genetic mutations successfully informed blood-thinner treatment selection following stent placement to open clogged blood vessels, leading to significantly fewer complications. Genetic testing identified patients with specific mutations that render the widely used blood thinner clopidogrel ineffective. Patients with the genetic mutations who received alternative medications were much less likely to die or have a heart attack, stroke or other complications than patients with the mutations who received clopidogrel. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 3, 2018 Category: International Medicine & Public Health Source Type: news

Going Generic OK for Clopidogrel
(MedPage Today) -- Non-inferiority achieved for ACS survivors in Canadian study (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 14, 2018 Category: American Health Source Type: news

New Studies Encourage Clopidogrel Genotyping New Studies Encourage Clopidogrel Genotyping
Two new studies suggest genotyping patients with ACS or those undergoing PCI to identify poor clopidogrel responders influences decision making on drug therapy by the interventionalist and may lead to benefits in outcomes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 12, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

TREAT: Ticagrelor Safe in STEMI Patients After Fibrinolysis TREAT: Ticagrelor Safe in STEMI Patients After Fibrinolysis
Randomized but open-label data show ticagrelor was noninferior to clopidogrel in terms of major bleeding at 30 days for patients with ST-segment elevation MI.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 12, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Ticagrelor Can Safely Follow Lytic Tx for STEMI
(MedPage Today) -- Bleeding similar upon delayed adminstration of ticagrelor versus clopidogrel (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 11, 2018 Category: Cardiology Source Type: news

Ticagrelor for Stroke: Encouraging Results in Platelet Study Ticagrelor for Stroke: Encouraging Results in Platelet Study
Ticagrelor was associated with a lower rate of high on-treatment platelet reactivity than clopidogrel in Asian patients who had had a minor stroke or high-risk TIA in the PRINCE trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 23, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Aspirin vs. Plavix
Title: Aspirin vs. PlavixCategory: MedicationsCreated: 2/14/2018 12:00:00 AMLast Editorial Review: 2/14/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 14, 2018 Category: Cardiology Source Type: news

Aspirin vs. Plavix (clopidogrel)
Title: Aspirin vs. Plavix (clopidogrel)Category: MedicationsCreated: 2/14/2018 12:00:00 AMLast Editorial Review: 2/14/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 14, 2018 Category: Cardiology Source Type: news

Acute coronary syndromes -- Did prasugrel & ticagrelor offer same benefits as clopidogrel?
(Bentham Science Publishers) In patients presenting with acute coronary syndromes (ACS) either with or without ST-segment elevation MI (STEMI and NSTEMI), dual antiplatelet therapy (DAPT) is recommended for at least 1 year independently of whether revascularization is performed. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2018 Category: International Medicine & Public Health Source Type: news

Ibuprofen and Plavix (Side Effects and Interactions)
Title: Ibuprofen and Plavix (Side Effects and Interactions)Category: MedicationsCreated: 2/2/2018 12:00:00 AMLast Editorial Review: 2/2/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 2, 2018 Category: Cardiology Source Type: news

Coumadin vs. Plavix (Differences and Similarities)
Title: Coumadin vs. Plavix (Differences and Similarities)Category: MedicationsCreated: 2/1/2018 12:00:00 AMLast Editorial Review: 2/1/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 1, 2018 Category: Cardiology Source Type: news

Recall of medication for high risk heart attack and stroke patients: Clopidogrel, sold as Plavix, has been mislabeled and recalled
(Natural News) International Laboratories voluntarily recalled a single lot of its clopidogrel tablets largely due to drug mislabeling, a Cardiovascular Business report revealed. According to the report, bottles of 30 tablets contained simvastatin instead of clopidogrel. The company sent out letters to its distributors and customers to alert them of the error. International Laboratories also arranged for a return of... (Source: NaturalNews.com)
Source: NaturalNews.com - January 19, 2018 Category: Consumer Health News Source Type: news

Clopidogrel Tablets Recalled, May Contain Simvastatin Clopidogrel Tablets Recalled, May Contain Simvastatin
International Laboratories issued the recall because the tablets, labeled as clopidogrel 75 mg, may contain the cholesterol-lowering drug simvastatin, an FDA safety alert notes.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 11, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

International Laboratories, LLC Issues Voluntary Nationwide Recall of one (1) Lot of Clopidogrel Tablets USP, 75 mg packaged in bottles of 30 tablets Due to Mislabeling NDC # 54458-888-16; Lot # 117099A
International Laboratories, LLC is voluntarily recalling Lot# 117099A of Clopidogrel Tablets, USP 75 mg, packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Clopidogrel tablets USP 75 mg but may contain Clopidogrel 75mg or Simvastatin Tablets USP 10 mg. (Source: Food and Drug Administration)
Source: Food and Drug Administration - January 10, 2018 Category: Food Science Source Type: news